Ad-hoc disclosure 📈 Stocks 🌍 Switzerland ISIN CH1262055788

EvoNext Holdings Reports Ascend Sport Technology FY 2025/26 Audited Results

Ascend Sport Technology AG posted strong FY 2025/26 results with 43.8 million CHF in revenue, though EvoNext Holdings shareholders face substantial dilution from the issuance of 199,999,978 merger consideration shares.

🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: EVON → 4/10 (50% confidence).

📊 Affected Assets (1)

EVON
Neutral 🤖 50%
📅 Short-term 🌍 CH · Explicit

The audited figures of Ascend Sport Technology AG show growth: net revenues of 43.8 vs 37.3 million CHF and EBITDA of 25.0 vs 18.9 million CHF in FY 2025/26, with equity rising to 76.0 million CHF. That supports the merger economics, but the share bridge shows about 200.0 million merger consideration shares against only 7,230,626 existing EvoNext shares, a massive dilution that offsets the positive figures for current holders.

Catalysts
  • • Audited FY 2025/26 results of Ascend Sport Technology AG: revenues 43.8 million CHF (prior year 37.3), EBITDA 25.0 million CHF (prior year 18.9)
  • • Merger share issuance of 199,999,978 consideration shares vs 7,230,626 existing shares
Risk Factors
  • • Extreme dilution: total shares post transaction reach 215,999,978, plus an 8,000,000 greenshoe
  • • Financial liabilities of 2.6 million CHF remain, though down from 4.0 million CHF

🎯 Key Takeaways

  • Ascend Sport Technology AG reported FY 2025/26 net revenues of 43.8 million CHF, up from 37.3 million CHF in the prior year.
  • EBITDA for the period reached 25.0 million CHF, compared to 18.9 million CHF in FY 2024/25.
  • Total equity for the entity rose to 76.0 million CHF, while financial liabilities decreased to 2.6 million CHF.
  • The merger transaction involves the issuance of 199,999,978 consideration shares against 7,230,626 existing EvoNext shares, resulting in a total post-transaction share count of 215,999,978.

📝 Executive Summary

EvoNext Holdings SA has released the audited financial statements for Ascend Sport Technology AG for the 2025/26 fiscal year. While the subsidiary reported growth with net revenues reaching 43.8 million CHF and EBITDA rising to 25.0 million CHF, the transaction structure introduces significant dilution for existing shareholders.

❓ FAQ

What does this mean for EvoNext shareholders?

The acquired business is growing, but the transaction adds roughly 200 million new consideration shares versus about 7.2 million existing shares, which heavily dilutes current holders.